Is Albireo Pharma Inc (ALBO) Stock a Smart Investment Wednesday? – InvestorsObserver

Albireo Pharma Inc (ALBO) stock has fallen -40.01% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives ALBO stock a score of 29 out of a possible 100.

That rank is mainly influenced by a long-term technical score of 5. ALBO’s rank also includes a short-term technical score of 12.

Overall Score - 29
ALBO has an Overall Score of 29. Find out what this means to you and get the rest of the rankings on ALBO!

What’s Happening with ALBO Stock Today

Albireo Pharma Inc (ALBO) stock has fallen -1.53% while the S&P 500 has fallen -0.63% as of 1:47 PM on Wednesday, Jun 1. ALBO has fallen -$0.31 from the previous closing price of $19.93 on volume of 130,585 shares. Over the past year the S&P 500 is down -2.28% while ALBO has fallen -40.01%. ALBO lost -$1.75 per share in the over the last 12 months. Click Here to get the full Stock Report for Albireo Pharma Inc stock.
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You’re all set to receive the Morning Update newsletter
Stock Price data may be delayed up to 15 minutes.
Copyright © 2022. Portions of this content may be copyrighted by Fresh Brewed Media, Investors Observer, and/or O2 Media LLC. All Rights Reserved. Portions of this content protected by US Patent numbers 7,865,496, 7,856,390, and 7,716,116. Investing in stocks, bonds, option and other financial instruments involve risks and may not be suitable for everyone. Portfolio results are unaudited and based on varying investment expiration dates. Terms of Service | Privacy Policy


Leave a Reply

Your email address will not be published.